Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stroncek

Showing results (151-160 of 213) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
BMC Genomics|April 28, 2012
The stable traits of melanoma genetics: an alternate approach to target discoveryTara L Spivey, Valeria De Giorgi, Yingdong Zhao, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Journal of Translational Medicine|February 3, 2026
Alpha-gal sensitization and allergic blood transfusion reactions: a scoping reviewMaureen J Miller, Roya Zarpak, Patricia Lee, et al.
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
BMC Genomics|July 9, 2009
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapyAndrea Worschech, Nanhai Chen, Yong A Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2019
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell CharacteristicsSandhya R Panch, Sandeep K Srivastava, Nasha Elavia, et al.
Cytotherapy|December 9, 2024
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapyRoshini Traynor, Isabella Vignola, Sarmila Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Pageof 22

Showing results (151-160 of 213) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2011
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignanciesStephan Mielke, Zachariah A McIver, Aarthy Shenoy, et al.
BMC Genomics|April 28, 2012
The stable traits of melanoma genetics: an alternate approach to target discoveryTara L Spivey, Valeria De Giorgi, Yingdong Zhao, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Journal of Translational Medicine|February 3, 2026
Alpha-gal sensitization and allergic blood transfusion reactions: a scoping reviewMaureen J Miller, Roya Zarpak, Patricia Lee, et al.
Blood Advances|November 8, 2023
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trialJennifer N Brudno, Danielle A Natrakul, Jeremiah Karrs, et al.
Blood|May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignanciesMarianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
BMC Genomics|July 9, 2009
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapyAndrea Worschech, Nanhai Chen, Yong A Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2019
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell CharacteristicsSandhya R Panch, Sandeep K Srivastava, Nasha Elavia, et al.
Cytotherapy|December 9, 2024
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapyRoshini Traynor, Isabella Vignola, Sarmila Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Pageof 22